[go: up one dir, main page]

Weigle et al., 1960 - Google Patents

Anaphylactogenic properties of soluble antigen-antibody complexes in the guinea pig and rabbit

Weigle et al., 1960

View PDF
Document ID
365877413268493312
Author
Weigle W
Cochrane C
Dixon F
Publication year
Publication venue
The Journal of Immunology

External Links

Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Weigle et al. Anaphylactogenic properties of soluble antigen-antibody complexes in the guinea pig and rabbit
Benacerraf et al. A quantitative study of the Arthus phenomenon induced passively in the guinea pig
French et al. Immunological enhancement of rat kidney grafts
McCluskey et al. The pathologic effects of intravenously administered soluble antigen-antibody complexes: I. Passive serum sickness in mice
Norman et al. Studies on allergoids from naturally occurring allergens IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever
Lee Antigen-antibody reaction in the pathogenesis of bilateral renal cortical necrosis
Yü et al. Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: a study in interactions between drugs
McCluskey et al. Localization of colloidal substances in vascular endothelium. A mechanism of tissue damage: II. Experimental serum sickness with acute glomerulonephritis induced passively in mice by antigen-antibody complexes in antigen excess
US5780026A (en) Immunomodulating and antiinflammatory agent
Bartfeld et al. Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor.
DE3887031T2 (en) Form of administration for an antagonist of gamma interferon for controlling a GHK-associated autoimmune disease.
Bolton et al. Thrombocytopenic Purpura Due to Quinidine I. Clinical Studies
Weigle et al. Relationship of circulating antigen-antibody complexes, antigen elimination, and complement fixation in serum sickness.
DE3701066A1 (en) INTRAVENOE INJECTABLE IMMUNOGLOBULIN WITH HIGH ANTI-CERTIFICITY TO THE RESPIRATORY SYNCYTIAL VIRUS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATION WHICH CONTAINS THIS
Hübner et al. Depression of the Primary Immune Response by dl-Penicillamine.
Altman et al. Suppression of the Primary Immune Response Induced by DL Penicillamine.
Weigle The immune response of BSA tolerant rabbits to injections of BSA following the termination of the tolerant state
Thomson et al. Defibrination with ancrod in experimental chronic immune complex nephritis
Wright An evaluation of anticoagulant therapy
Aten et al. Antigenic specificities of glomerular-bound autoantibodies in membranous glomerulopathy induced by mercuric chloride
Lepow et al. STUDIES ON IMMUNE CELLULAR INJURY: II. Functional Role of C'1 Esterase in Immune Cytotoxicity
Cathcart et al. Cellular immunity in casein-induced amyloidosis
Miller et al. Production of acute glomerulonephritis in mice with soluble antigen-antibody complexes prepared from homologous antibody.
Cadroy et al. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin
DE69230614T2 (en) PROTEIN-S POLYPEPTIDES AND THEIR USE